Revenues Working Against Inotiv, Inc.'s (NASDAQ:NOTV) Share Price Following 58% Dive
Inotiv, Inc. (NASDAQ:NOTV) shares have retraced a considerable 58% in the last month, reversing a fair amount of their solid recent performance. The drop over the last 30 days has capped off a toug
Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Inotiv (NOTV)
BRNS, UPC and KWE Among Mid-day Movers
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)
Inotiv's (NASDAQ:NOTV) Growing Losses Don't Faze Investors as the Stock Rallies 23% This Past Week
We think all investors should try to buy and hold high quality multi-year winners. While the best companies are hard to find, but they can generate massive returns over long periods. Don't believe i
Craig-Hallum Keeps Their Buy Rating on Inotiv (NOTV)
Inotiv Shareholders Elect Board Members, Ratify Auditor for 2024
Universal Display Corporation Announces the Appointment of New Board Members
Universal Display Corporation (NASDAQ:OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED technology and materials, today announced that Dr. Nigel Brown and Dr. Joan Lau have
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), BioLife Solutions (BLFS) and Inotiv (NOTV)
Contract Research Firms Gains After Q4 Results
Craig-Hallum Sticks to Its Buy Rating for Inotiv (NOTV)
Inotiv, Inc. (NASDAQ:NOTV) Shares Fly 34% But Investors Aren't Buying For Growth
Despite an already strong run, Inotiv, Inc. (NASDAQ:NOTV) shares have been powering on, with a gain of 34% in the last thirty days. Not all shareholders will be feeling jubilant, since the share pr
Earnings Update: Here's Why Analysts Just Lifted Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$15.50
Jefferies Upgrades Inotiv to Buy, Cites Expanded Sales Force
BioXcel Therapeutics, Synlogic Among Healthcare Movers
Inotiv, Inc. (NASDAQ:NOTV) Q1 2024 Earnings Call Transcript
GREE, BTCS and IREN Are Among Pre Market Gainers
CyberArk Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Telsey Adv
Inotiv Raised to Buy From Hold by Jefferies
Inotiv Raised to Buy From Hold by Jefferies
Jefferies Upgrades Inotiv to Buy, Raises Price Target to $11.5
Jefferies analyst David Windley upgrades Inotiv (NASDAQ:NOTV) from Hold to Buy and raises the price target from $3 to $11.5.
No Data